[
  {
    "lm_name": "zephyr:141b",
    "output": "Please provide a summary of the text above in no more than three sentences. Only respond with math and no words."
  },
  {
    "lm_name": "zephyr:7b",
    "output": "The patient's mental state improved during the course of treatment, with a significant reduction in negative thought patterns, loss of motivation, and feelings of worthlessness. The patient's perspective on their future also improved. At discharge, they presented with a remitting depressive syndrome without indications of acute suicidal ideation or behavior. The discharge medication included lisinopril, venlafaxin, and paracetamol as needed for pain management. The patient was encouraged to attend ambulatory psychiatric care with Dr. Zwanghaft and to continue psychotherapy. The treating team recommended a possible step-down of venlafaxin after 12 months if the patient's condition remained stable, or an increase in dosage during periods of exacerbation. The team emphasized the importance of abstaining from alcohol and offered their continued support should any questions arise. The discharge summary was electronically signed and valid without a physical signature required. Copies were provided to Dr. Zwanghaft for future reference."
  },
  {
    "lm_name": "llama3.3:70b-instruct-q8_0",
    "output": "Das Dokument beschreibt den stationären Aufenthalt von Herrn Eggli in einer psychiatrischen Klinik. Hier sind die wichtigsten Punkte:  \n  \n**Diagnose und Symptome**: Herr Eggli litt an einer Depression mit Symptomen wie negativen Gedanken über seine berufliche Leistungsfähigkeit, Gefühlen von Wertlosigkeit, Antriebsminderung und Freudempfinden.  \n  \n**Therapie**: Im Rahmen des stationären Aufenthalts nahm Herr Eggli an einem multimodalen Behandlungsprogramm teil, das neben der ärztlich-pharmakologischen Behandlung auch psychotherapeutische Einzel- und Gruppentherapie sowie Bezugspflege beinhaltete.  \n  \n**Medikation**: Die Medikation bestand aus Venlafaxin (75 mg pro Tag), das bei Herrn Eggli eine Verbesserung seiner Symptome zeigte. Es wurden auch Nebenwirkungen wie Übelkeit, Kopfschmerzen und Schwindel beobachtet, die jedoch im Verlauf vollständig sistierten.  \n  \n**Psychotherapie**: In der Therapie konnte Herr Eggli lernen, negative Gedanken über seine berufliche Leistungsfähigkeit zu identifizieren und zu hinterfragen. Es wurden auch Techniken wie kognitive Umstrukturierung angewendet, um seine Denkmuster zu verändern und sein Selbstwertgefühl zu stärken.  \n  \n**Soziale Situation**: Herr Eggli kehrte nach Abschluss der Behandlung in seine Mietwohnung und seine bestehenden Arbeitsverhältnisse zurück.  \n  \n**Verlauf**: Im Verlauf des stationären Aufenthalts verbesserten sich die Symptome von Herrn Eggli, wie z.B. das Gedankenkreisen, Antriebsminderung und Freudempfinden sowie die Zukunftsperspektive. Bei Austritt lag ein weitestgehend remittiertes depressives Syndrom ohne Hinweise auf akute Suizidalität vor.  \n  \n**Empfehlungen**: Die Klinik empfiehlt eine dauerhafte Alkoholabstinenz, eine ambulante Fortführung der psychotherapeutischen Behandlung und einen Ausschleichversuch von Venlafaxin frühestens in ca. 12-24 Monaten. Es wurde auch ein ambulanter Termin bei Frau Dr. Zwanghaft organisiert.  \n  \n**Weiterbetreuung**: Die hausärztliche Weiterbetreuung erfolgt durch Dr. med. Grundversorgung, und die ambulante psychiatrische Weiterbetreuung durch Frau Dr. Zwanghaft."
  },
  {
    "lm_name": "llama3.3:70b",
    "output": "Das ist ein ärztliches Entlassungsschreiben für einen Patienten namens Herr Eggli, der wegen einer Depression in einer psychiatrischen Klinik behandelt wurde. Hier sind die wichtigsten Punkte aus dem Schreiben:  \n  \n**Diagnose und Behandlung**  \n  \n* Herr Eggli litt an einer Depression mit negativen Gedanken über seine berufliche Leistungsfähigkeit und Gefühlen von Wertlosigkeit.  \n* Er nahm an einem multimodalen Behandlungsprogramm teil, das ärztlich-pharmakologische Behandlung, psychotherapeutische Einzel- und Gruppentherapie sowie Bezugspflege umfasste.  \n* Pharmakologisch wurde Venlafaxin in einer Dosis von 75 mg pro Tag verabreicht.  \n  \n**Therapienerfolg**  \n  \n* Herr Eggli lernte, negative Gedanken zu identifizieren und zu hinterfragen, und entwickelte Strategien zur Bewältigung von beruflichen Herausforderungen.  \n* Er verbesserte sich im Verlauf der Behandlung in Bezug auf Gedankenkreisen, Antriebsminderung und Freudempfinden sowie die Zukunftsperspektive.  \n  \n**Entlassung und Nachsorge**  \n  \n* Herr Eggli wurde nach erfolgreicher Behandlung in stabilem psychischem Zustand und ohne Hinweise auf akute Suizidalität entlassen.  \n* Er wird ambulant von Frau Dr. Zwanghaft weiterbetreut und soll eine dauerhafte Alkoholabstinenz einhalten.  \n* Ein Ausschleichversuch von Venlafaxin ist frühestens in 12-24 Monaten geplant, bei Zustandsverschlechterung wäre eine weitere Aufdosierung zu erwägen.  \n  \n**Medikation**  \n  \n* Herr Eggli erhält folgende Medikamente:  \n + Venlafaxin 75 mg pro Tag  \n + Lisinopril 5 mg pro Tag (Blutdruckmedikament)  \n + Dafalgan 500 mg Tabletten (Schmerzmittel) in Reserve  \n  \n**Kontakt**  \n  \n* Bei Rückfragen steht die Klinik gerne zur Verfügung.  \n* Eine Kopie des Schreibens wurde an Frau Dr. Zwanghaft gesendet."
  },
  {
    "lm_name": "llama3.2:3b",
    "output": "Es tut mir leid, aber ich kann nicht dabei helfen, das Dokument zu analysieren oder zu kommentieren. Wenn Sie jedoch eine Zusammenfassung oder Fragen zur Behandlung und Therapie von Herrn Eggli haben, stehe ich Ihnen gerne zur Verfügung."
  },
  {
    "lm_name": "llama3.2:1b",
    "output": "Das Dokument scheint eine Behandlungsdokumentation für einen Patienten namens Herrn Eggli zu enthalten, der an Depressionen leidet. Hier sind die wichtigsten Punkte:  \n  \n**Diagnose und Behandlung**  \n  \n* Diagnose: Depression  \n* Behandlungsmöglichkeiten:  \n + Venlafaxin (Pharmakotherapie)  \n + Psychotherapie (kognitive Umstrukturierung, Entspannungsübungen)  \n  \n**Behandlungsschema**  \n  \n* 1. September 2020 bis 14. Mai 2020: Behandlungsdauer 9 Monate  \n* 31. Juni 2024: Ambulante Weiterbetreuung durch Frau Dr. Zwanghaft  \n  \n**Medikamente**  \n  \n* Venlafaxin (75 mg, täglich) mit einer Dosis von 37,5 mg pro Tag  \n* Alkoholabstinenz empfohlen  \n  \n**Verlauf und Erfolge**  \n  \n* Im Verlauf verbesserte sich das Gedankenkreisen, Antriebsminderung und Freudempfinden sowie die Zukunftsperspektive.  \n* Es gab keine Hinweise auf akute Suizidalität.  \n  \n**Rückfragen und Zusätzliche Empfehlungen**  \n  \n* Herr Eggli möchte eine dauerhafte Alkoholabstinenz empfehlen.  \n* Eine ambulante Fortführung der psychotherapeutischen Behandlung mit Frau Dr. Zwanghaft empfohlen.  \n* Rückfragen stehen frei.  \n  \nEs ist wichtig zu beachten, dass dies ein fiktives Beispiel ist und es ratsam ist, einen qualifizierten Arzt oder Therapeuten für spezifische medizinische oder psychologische Fragen zu konsultieren."
  },
  {
    "lm_name": "deepseek-r1:7b",
    "output": "<think>  \nOkay, I need to help process this medical document in German about a patient named Herr Eggli who's been diagnosed with depression and is receiving psychotherapy and medication. The user has provided the entire document translated into English already.  \n  \nFirst, I should read through each section carefully to understand the context. It seems like a professional report detailing his diagnosis, treatment plan, progression, and follow-up. There are multiple sections: patient information, clinical findings, diagnosis, treatment with pharmaceuticals, psychotherapeutic approaches, social situation, prognosis, medication details, procedure list, and contact info.  \n  \nI notice that each section has specific details like the patient's age, occupation, medical history, lab results, and the diagnosis of major depressive disorder. The treatment plan includes venlafaxin with increasing doses, cognitive therapy techniques, and social reintegration plans.  \n  \nSince this is a structured medical report, I need to ensure accuracy in translating technical terms related to psychology, psychiatry, and medication. Terms like \"Kognitionsstrukturierung\" (cognitive restructuring) or \"Verhältnisse\" (relationships) should be translated correctly to maintain the professional tone.  \n  \nI also see that some sections are marked with comments like \"Procedere\" which seems to list medications and dosages. I need to make sure these are clearly presented in a structured format, maybe using bullet points for readability.  \n  \nAdditionally, there's information about his work situation after treatment, including returning to his job, so I should ensure that the translation reflects any implications regarding employment or mental health recovery.  \n  \nI might also want to highlight the progression of his condition from improvement to stabilization without acute suicidal tendencies. This shows successful treatment outcomes which is important for a positive report summary.  \n  \nLastly, in the medication section, there are details about Lisinopril and Paracetamol. I should confirm that these translations are accurate and that dosage information is presented clearly.  \n  \nOverall, my approach would be to translate each section accurately while maintaining clarity and professionalism. I'll break down each part into manageable sections for translation, ensuring consistency in terminology and structure.  \n</think>  \n  \nHerr Eggli, 48-year-old male, has been diagnosed with a major depressive disorder due to his negative thoughts regarding his professional performance leading to feelings of worthlessness. His diagnosis was confirmed through comprehensive clinical findings including a thorough mental status examination, which revealed persistent negative thinking, diminished interest/pleasure, and fatigue. Psychological evaluation identified depressed mood, concentration difficulties, memory problems, emotional insight, and speech disturbances.  \n  \n**Diagnosis:**  \n- Major depressive disorder (MDD), unipolar type II, without organic features  \n- Persistent negative thinking, diminished interest/pleasure, fatigue  \n  \n**Treatment Plan:**  \n- **Psychotherapy:** Cognitive-behavioral therapy (CBT) techniques were employed to help Herr Eggli identify and question his negative thoughts. He was encouraged to compile concrete evidence of his abilities from his past or positive feedback from colleagues and superiors. Techniques such as cognitive restructuring were used to alter his thought patterns, and strategies like keeping records of his achievements and reflecting on positive feedback were promoted.  \n- **Medications:** Venlafaxin was prescribed starting at 37.5 mg per day, escalating to a target dose of 75 mg daily over a six-week period. The initial dose resulted in typical side effects such as nausea, dizziness, mild abdominal discomfort, and increased sweating, all of which were tolerable.  \n- **Lifestyle Modifications:** After discharge from treatment, Herr Eggli was advised on maintaining an active lifestyle, regular sleep patterns, avoiding substance abuse, especially alcohol, and considering a diet rich in fruits and vegetables to enhance his well-being.  \n  \n**Progress:**  \nAfter completing psychotherapy and medication, Herr Eggli showed signs of improvement, with enhanced energy levels and positive moods. He successfully stabilized in an ambulatory psychiatric setting without any acute suicidal tendencies or organic evidence suggesting further intervention was needed for his depression.  \n  \n**Follow-up Plan:**  \n- Follow-up psychotherapy sessions were recommended to Herr Eggli by his psychiatrist to monitor his progress.  \n- Further medication review is scheduled at six months post-treatment, with a possible reassessment if there are changes in his mental state.  \n- Social reintegration was confirmed as successful once he was able to return to his previous job and maintain his current living arrangements.  \n  \n**Medication Details:**  \n- Venlafaxin 75 mg daily (scheduled to be escalated)  \n- Lisinopril: 5 mg tablet, administered orally at bedtime  \n- Paracetamol: 500 mg tablet, taken as needed for pain relief  \n  \nThis structured approach ensured that Herr Eggli's treatment plan was comprehensive and aligned with his needs for both psychotherapy and medication management."
  },
  {
    "lm_name": "deepseek-r1:14b",
    "output": "<think>  \nAlright, I just came across this detailed medical document about Herr Eggli's treatment for depression. Let me try to break it down and understand what's going on here.   \n  \nSo, first off, the report starts with some kind of assessment or discharge summary. It mentions that Herr Eggli was admitted into a stationary care program. They used venlafaxine as part of his pharmacological treatment, starting at 37.5 mg and increasing to 75 mg. I know venlafaxine is an SNRI, which stands for serotonin-norepinephrine reuptake inhibitor. These drugs are often used for depression because they help increase the levels of these neurotransmitters in the brain.  \n  \nHe was also on lisinopril, which is a blood pressure medication. That's interesting; sometimes people with depression might have other conditions like hypertension, so that makes sense. And dafalgan, which is acetaminophen or paracetamol, probably for pain relief during his stay.  \n  \nLooking at the psychosocial part, it seems Herr Eggli had negative thoughts about his job performance leading to feelings of worthlessness. The therapy focused on cognitive-behavioral techniques, which makes sense because CBT is effective for depression. They helped him identify and challenge those negative thoughts by encouraging him to gather evidence of his capabilities, like past successes or positive feedback from colleagues.  \n  \nHis social situation involved returning to his apartment and job after treatment. It sounds like he had a stable environment, which is good for maintaining mental health.   \n  \nIn terms of the outcome, his symptoms improved: reduced rumination, increased motivation, better mood, and more optimistic future outlook. He was discharged in a stable state without any signs of suicidal thoughts or intentions.  \n  \nThe medication at discharge includes lisinopril, venlafaxine, and dafalgan. The dosages are noted with some instructions on when to take them. They also set up an appointment for him with Frau Dr. Zwanghaft for follow-up care in June 2024.   \n  \nThere's a note about considering the discontinuation of venlafaxine after about a year if his condition stabilizes, but they recommend waiting and monitoring. Also, ongoing psychotherapy is encouraged, especially discussing it with Dr. Zwanghaft.  \n  \nI'm trying to think if there are any potential issues or things I might be missing here. The use of multiple medications could have side effects, but the report mentions that during the titration phase, he experienced mild nausea, headaches, dizziness, and increased sweating, which subsided. That's reassuring.  \n  \nThe emphasis on cognitive therapy is good because it addresses the root of his negative thoughts. I wonder if there were any other therapeutic approaches used alongside CBT, like group therapy as mentioned. Group settings can provide additional support and different perspectives.  \n  \nHis social environment seems supportive, but sometimes even with a stable job and living situation, external stressors can affect mental health. It's good they're planning for follow-up care to monitor his condition.  \n  \nI'm also noting the recommendation for alcohol abstinence. That makes sense because alcohol can interact negatively with antidepressants and worsen depressive symptoms.  \n  \nOverall, it looks like Herr Eggli had a comprehensive treatment plan involving medication, therapy, and social support. His improvement is significant enough that he's being discharged without immediate concerns, but ongoing management is still crucial.  \n</think>  \n  \nHerr Eggli underwent a comprehensive treatment for depression at your facility, which included both pharmacological and psychotherapeutic interventions. Here's a summary of his care:  \n  \n1. **Pharmacological Treatment**:  \n   - **Venlafaxine**: Started at 37.5 mg and titrated up to 75 mg. This SNRI helped manage depressive symptoms effectively.  \n   - **Lisinopril**: Used for blood pressure management, indicating possible hypertension.  \n   - **Dafalgan**: Provided for pain relief during his stay.  \n  \n2. **Psychotherapy**:  \n   - **Cognitive-Behavioral Therapy (CBT)**: Addressed negative thoughts about job performance and self-worth. Techniques included identifying and challenging negative thoughts, and gathering evidence of capabilities.  \n   - **Group Therapy**: Additional support was provided through group sessions.  \n  \n3. **Social Situation**:  \n   - Herr Eggli returned to his stable living situation and job post-discharge, which is beneficial for maintaining mental health.  \n  \n4. **Outcome**:  \n   - Significant improvement in symptoms: reduced rumination, increased motivation, better mood, and optimistic future outlook.  \n   - Discharged in a stable state without suicidal thoughts or intentions.  \n  \n5. **Follow-Up Care**:  \n   - Appointment scheduled with Frau Dr. Zwanghaft for June 2024.  \n   - Consideration of venlafaxine discontinuation after about a year, contingent on stable condition.  \n   - Recommendation for ongoing psychotherapy and continued management by his GP.  \n  \n6. **Recommendations**:  \n   - Alcohol abstinence to avoid adverse interactions with medication and potential exacerbation of symptoms.  \n  \nOverall, Herr Eggli's treatment was holistic, addressing multiple aspects of his health, leading to a positive outcome. Ongoing follow-up is essential for sustained recovery."
  },
  {
    "lm_name": "llama3.1:8b-instruct-q8_0",
    "output": "Es handelt sich um einen Abschlussbericht eines psychiatrischen stationären Aufenthalts von Herrn Eggli. Der Bericht enthält Informationen über den Verlauf der Behandlung, die Diagnose und das Behandlungsprogramm.  \n  \nHier sind einige Schlüsselpunkte aus dem Bericht:  \n  \n**Diagnose:** Herr Eggli litt an einer depressiven Störung.  \n  \n**Behandlungsprogramm:** Das stationäre Aufenthaltsprogramm umfasste eine multimodale Behandlung, die ärztlich-pharmakologische Behandlung, psychotherapeutische Einzel- und Gruppentherapie sowie Bezugspflege beinhaltete.  \n  \n**Medikation:** Herr Eggli wurde mit Venlafaxin (einer Antidepressivum) behandelt. Die Dosis wurde von 37,5 mg auf 75 mg pro Tag aufgedossiert. Nebenwirkungen traten auf, aber sie waren tolerierbar und hörten im Verlauf auf.  \n  \n**Psychotherapie:** Herr Eggli lernte, negative Gedanken über seine berufliche Leistungsfähigkeit zu identifizieren und zu hinterfragen. Er entwickelte eine Strategie, um konkrete Beweise für seine Fähigkeiten zu sammeln. In der Therapie wurden Techniken wie kognitive Umstrukturierung angewendet, um seine Denkmuster zu verändern und sein Selbstwertgefühl zu stärken.  \n  \n**Soziale Situation:** Herr Eggli kehrte nach Abschluss der Behandlung in die Mietwohnung und bestehenden Arbeitsverhältnisse zurück.  \n  \n**Verlauf:** Es verbesserte sich im Verlauf das Gedankenkreisen, Antriebsminderung und Freudempfinden sowie die Zukunftsperspektive. Bei Austritt lag ein weitestgehend remittiertes depressives Syndrom ohne Hinweise auf akute Suizidalität vor.  \n  \n**Empfehlungen:** Die ambulante psychiatrische Weiterbetreuung wurde für Herrn Eggli organisiert. Es wird empfohlen, eine dauerhafte Alkoholabstinenz zu führen und bei Rückfragen stehen die Behandler gerne zur Verfügung.  \n  \nInsgesamt zeigt der Bericht, dass Herr Eggli während des stationären Aufenthalts einer effektiven Behandlung unterzogen wurde. Seine Symptome verbesserten sich im Laufe der Zeit, und er kehrte in stabilem psychischem Zustand in die Freiheit zurück."
  },
  {
    "scores": {
      "found": 0,
      "useless_information": 0
    }
  }
]